Beyond-the-Needle Initiative of Nano PharmaSolutions for Fighting COVID-19
Nano PharmaSolutions is developing remedesivir as dry powder for inhalation (DPI) formulation to make it available for everyone at early stage of infection.
NANO PHARMASOLUTIONS IN THE NEWS
NPS’ NanoTransformer™ Technology Featured in Drug Development & Delivery
In drug-dev.com's special feature report, Solubility & Bioavailability: Difficult Beasts to Tame, NPS explains how chemical & additive free nanoformulation tackles solubility and enhances bioavailability. You can read the full [...]
Mikart and Nano PharmaSolutions have entered into a collaboration agreement:
Nano PharmaSolutions (“NPS”) has entered into a collaboration agreement with Mikart, LLC ("Mikart") a comprehensive contract development and manufacturing organization in Atlanta, GA. Read the full PR Newswire article: Here [...]
Women In Bio – NPS CEO Speaks at BIO 2022
This year Dr. Olmstead spoke at BIO International Conference representing Nano PharmaSolutions and Women in BIO. Dr. Olmstead also spoke on topics of inclusion and diversity in life science research [...]
NPS CEO to Speak at 2022 BIO International Conference
Dr. Olmstead will be speaking on a panel focusing on Health Disparity Other topics of the panel include disparities in healthcare for women, funding access, and how women founders are [...]